Latest Insider Transactions at Silverback Therapeutics, Inc. (SBTX)
This section provides a real-time view of insider transactions for Silverback Therapeutics, Inc. (SBTX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Silverback Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Silverback Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 23
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
130,993
+1.9%
|
$130,993
$1.14 P/Share
|
|
Apr 23
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
130,993
+1.9%
|
$130,993
$1.14 P/Share
|
|
Apr 19
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
188,491
+2.16%
|
$188,491
$1.14 P/Share
|
|
Apr 19
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Indirect |
188,491
+2.16%
|
$188,491
$1.14 P/Share
|
|
Apr 16
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
100,000
-2.79%
|
$900,000
$9.28 P/Share
|
|
Apr 16
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
100,000
-2.79%
|
$900,000
$9.28 P/Share
|
|
Apr 09
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
100,000
-2.76%
|
$900,000
$9.28 P/Share
|
|
Apr 09
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
100,000
-2.76%
|
$900,000
$9.28 P/Share
|
|
Mar 27
2024
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
505,954
+4.84%
|
$4,553,586
$9.79 P/Share
|
|
Mar 26
2024
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
457,745
+4.62%
|
$4,119,705
$9.55 P/Share
|
|
Mar 25
2024
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
437,600
+4.64%
|
$3,938,400
$9.06 P/Share
|
|
Mar 25
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
95,267
-2.56%
|
$857,403
$9.12 P/Share
|
|
Mar 25
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
95,267
-2.56%
|
$857,403
$9.12 P/Share
|
|
Mar 22
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
2,343
-0.06%
|
$21,087
$9.02 P/Share
|
|
Mar 22
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
2,343
-0.06%
|
$21,087
$9.02 P/Share
|
|
Mar 21
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
472
-0.01%
|
$4,248
$9.0 P/Share
|
|
Mar 21
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
472
-0.01%
|
$4,248
$9.0 P/Share
|
|
Mar 19
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
1,918
-0.05%
|
$17,262
$9.04 P/Share
|
|
Mar 19
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
1,918
-0.05%
|
$17,262
$9.04 P/Share
|
|
Mar 15
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
96,756
-2.57%
|
$870,804
$9.14 P/Share
|
|
Mar 15
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
96,756
-2.57%
|
$870,804
$9.14 P/Share
|
|
Mar 14
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
444
-0.01%
|
$3,996
$9.0 P/Share
|
|
Mar 14
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
444
-0.01%
|
$3,996
$9.0 P/Share
|
|
Mar 13
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
2,800
-0.07%
|
$25,200
$9.0 P/Share
|
|
Mar 13
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
2,800
-0.07%
|
$25,200
$9.0 P/Share
|
|
Feb 29
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
3,782
-0.07%
|
$34,038
$9.02 P/Share
|
|
Feb 29
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
3,782
-0.07%
|
$34,038
$9.02 P/Share
|
|
Feb 28
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
98,778
-1.71%
|
$889,002
$9.02 P/Share
|
|
Feb 28
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
98,778
-1.71%
|
$889,002
$9.02 P/Share
|
|
Feb 26
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
700
-0.01%
|
$6,300
$9.01 P/Share
|
|
Feb 26
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
700
-0.01%
|
$6,300
$9.01 P/Share
|
|
Sep 29
2023
|
Alexander A Fitzpatrick Chief Legal Officer |
BUY
Open market or private purchase
|
Direct |
46,258
+34.14%
|
$138,774
$3.78 P/Share
|
|
Sep 28
2023
|
Alexander A Fitzpatrick Chief Legal Officer |
BUY
Open market or private purchase
|
Direct |
40,000
+48.21%
|
$120,000
$3.62 P/Share
|
|
Sep 21
2023
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
2,700,000
+12.63%
|
$8,100,000
$3.4 P/Share
|
|
Sep 01
2023
|
Laura Shawver |
SELL
Open market or private sale
|
Direct |
100,000
-32.22%
|
$700,000
$7.71 P/Share
|
|
Sep 01
2023
|
Laura Shawver |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+12.6%
|
$100,000
$1.27 P/Share
|
|
Aug 29
2023
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
500,000
+5.87%
|
$3,000,000
$6.2 P/Share
|
|
Aug 29
2023
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
3,750,000
+39.04%
|
$22,500,000
$6.2 P/Share
|
|
Aug 29
2023
|
Peter A. Thompson Director |
BUY
Open market or private purchase
|
Indirect |
500,000
+5.87%
|
$3,000,000
$6.2 P/Share
|
|
Aug 04
2023
|
Laura Shawver |
SELL
Open market or private sale
|
Direct |
18,897
-8.24%
|
$132,279
$7.06 P/Share
|
|
Aug 04
2023
|
Laura Shawver |
BUY
Exercise of conversion of derivative security
|
Direct |
18,897
+7.62%
|
$18,897
$1.27 P/Share
|
|
Aug 03
2023
|
Laura Shawver |
SELL
Open market or private sale
|
Direct |
26,107
-11.04%
|
$182,749
$7.01 P/Share
|
|
Aug 03
2023
|
Laura Shawver |
BUY
Exercise of conversion of derivative security
|
Direct |
26,107
+9.94%
|
$26,107
$1.27 P/Share
|
|
Aug 02
2023
|
Laura Shawver |
SELL
Open market or private sale
|
Direct |
36,281
-14.71%
|
$253,967
$7.09 P/Share
|
|
Aug 02
2023
|
Laura Shawver |
BUY
Exercise of conversion of derivative security
|
Direct |
36,281
+12.82%
|
$36,281
$1.27 P/Share
|
|
Aug 01
2023
|
Laura Shawver |
SELL
Open market or private sale
|
Direct |
18,715
-8.17%
|
$131,005
$7.19 P/Share
|
|
Aug 01
2023
|
Laura Shawver |
BUY
Exercise of conversion of derivative security
|
Direct |
18,715
+7.55%
|
$18,715
$1.27 P/Share
|
|
Jul 07
2023
|
Laura Shawver |
SELL
Open market or private sale
|
Direct |
8,858
-4.04%
|
$53,148
$6.36 P/Share
|
|
Jul 07
2023
|
Laura Shawver |
BUY
Exercise of conversion of derivative security
|
Direct |
8,858
+3.88%
|
$8,858
$1.27 P/Share
|
|
Jul 06
2023
|
Laura Shawver |
SELL
Open market or private sale
|
Direct |
33,510
-13.74%
|
$201,060
$6.34 P/Share
|